Novel bladder cancer treatment gains MHRA approval in the UK

Share this article Boehringer will manufacture the antibody candidates on mini-scales and assess them experimentally as part of a validation process. Credit: IBM. Boehringer Ingelheim

Whole genome sequencing captured almost twice as many genetic abnormalities that may be responsible for disease in infants, compared with a standard targeted test, researchers

Com­pa­nies that make re­gen­er­a­tive med­i­cines like CAR-T ther­a­pies, gene-edit­ed stem cells and eye im­plants face a num­ber of chal­lenges that lim­it the de­vel­op­ment and use